22:27:27 EDT Sat 22 Jun 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Diagnos Inc (3)
Symbol ADK
Shares Issued 74,357,028
Close 2024-02-28 C$ 0.28
Market Cap C$ 20,819,968
Recent Sedar Documents

Diagnos appoints Braeuel as director

2024-02-29 14:46 ET - News Release

Mr. Andre Larente reports

DIAGNOS WELCOMES MR. MICHAEL BRAEUEL TO ITS BOARD OF DIRECTORS

Diagnos Inc. has appointed Michael Braeuel to the corporation's board of directors.

Mr. Braeuel has a successful record as an accomplished entrepreneur with over 30 years of hands-on business experience. Over the years, he has been able to establish, expand and ultimately sell two highly profitable businesses. One of them is providing engineering and systems integration services for machine vision inspection technology. Mr. Braeuel holds a master's degree in engineering.

"We are pleased that Michael has accepted to join the board. We are convinced that his extensive work experience will directly contribute to the growth of our business," said Andre Larente, president of Diagnos.

Mr. Braeuel's directorship is effective Feb. 29, 2024.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its Flaire artificial intelligence (AI) platform. Flaire allows for quick modifying and developing of applications such as CARA (computer-assisted retina analysis). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.